Clever Culture Systems Limited
CC5
Rang in aandelen
#27511
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Aandeelprijs
$0.0141057
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$30.78M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
32.83%
Land
AU
Handel Clever Culture Systems Limited (CC5)
Categorie
Healthcare
Winst voor Clever Culture Systems Limited (CC5)
Winst in Jun 2024 TTM: $-3.12M
Volgens de meest recente financiële verslagen van Clever Culture Systems Limited bedraagt de huidige winst van het bedrijf $-3.12M. In 2023 behaalde het bedrijf een winst van $-13.91M, een daling ten opzichte van de winst van 2022, die $-5.66M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Clever Culture Systems Limited van 2007 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-3.12M | 0.00% |
| 2024 | $-3.12M | -77.57% |
| 2023 | $-13.91M | 145.86% |
| 2022 | $-5.66M | 30.43% |
| 2021 | $-4.34M | 11.28% |
| 2020 | $-3.90M | -7.37% |
| 2019 | $-4.21M | 73.60% |
| 2018 | $-2.42M | -67.23% |
| 2017 | $-7.40M | -341.08% |
| 2016 | $3.07M | -1,286.43% |
| 2015 | $-258.70K | -71.75% |
| 2014 | $-915.89K | -370.88% |
| 2013 | $338.11K | -119.00% |
| 2012 | $-1.78M | -10.68% |
| 2011 | $-1.99M | -219.96% |
| 2010 | $1.66M | 689.45% |
| 2009 | $210.37K | -2.53% |
| 2008 | $215.84K | -77.99% |
| 2007 | $980.77K | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | -243,863.06% |
US
|
|
| $4.76B | -152,656.14% |
US
|
|
| $-252.70M | 7,995.57% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -53,215.93% |
US
|
